This is topic Nutra Pharma HOT NEWS in forum Hot Stocks Free for All ! at Allstocks.com's Bulletin Board.


To visit this topic, use this URL:
http://www.allstocks.com/stockmessageboard/ubb/ultimatebb.php/ubb/get_topic/f/2/t/010833.html

Posted by biotechguy0331 on :
 
Nutra Pharma Reports Preclinical Results of RPI-78M in Multiple Sclerosis to Be Presented at Scientific Meeting

BOYNTON BEACH, Fla.--Feb. 9, 2006--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that owns rights to intellectual property related to the development of drugs for HIV and Multiple Sclerosis, has announced that the studies using RPI-78M in an animal model of Multiple Sclerosis (MS) have been accepted for presentation and publication. RPI-78M is the lead drug candidate of Nutra Pharma's holding, ReceptoPharm, Inc. and is being studied in preclinical assays for its efficacy in treating MS.

Full release and amazing preclinical results at http://www.nutrapharma.com
 


© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2